Steroid-toxicity Insights Roundup
We are pleased by the response to our all-new STOX Digital Platform, which launched just last month. Now all STOX licensees can calculate validated scores using any or all of our clinical outcome assessments of steroid-toxicity.
In addition, we’re delighted to provide access to a free trial of the GTI-MD.
For those who would prefer a “90-second explainer” to share with their colleagues, we’ve developed a helpful little video - we hope you enjoy it!
Dan Hawcutt, MD MRCPCH is a reader in pediatric pharmacology at the University of Liverpool, and honorary consultant in pediatrics at Alder Hey Children’s Hospital. He is the director of Alder Hey’s early-phase clinical research facility, overseeing early-phase drug trials, and testing medicines, including steroids.
Glucocorticoid overuse represents a failure in asthma treatment planning especially for those with persistent exacerbations.
More patients die from complications associated with glucocorticoid treatment than from the underlying disease - but there is hope.
Steritas is working toward a world free of steroid dependency, enabling the measurement and monitoring of steroid-toxicity to optimize treatment of inflammatory diseases and improve the quality of patient care around the world.
Learn more at steritas.com.
Sincerely,
Martha Stone
CEO, Steritas